Alcon Inc.
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other product… Read more
Alcon Inc. (2U3) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: x
Based on the latest financial reports, Alcon Inc. (2U3) has a cash flow conversion efficiency ratio of x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€658.00 Million) by net assets (€0.00). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Alcon Inc. - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how Alcon Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Alcon Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Alcon Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ResMed Inc
NYSE:RMD
|
0.054x |
|
Orix Corp Ads
NYSE:IX
|
0.129x |
|
Medline Inc. Class A Common Stock
NASDAQ:MDLN
|
0.037x |
|
Bank Rakyat
PINK:BKRKY
|
0.124x |
|
Orange SA
XETRA:FTE
|
0.144x |
|
Chunghwa Telecom Co Ltd
NYSE:CHT
|
0.080x |
|
Keurig Dr Pepper Inc
NASDAQ:KDP
|
0.028x |
|
Archer-Daniels-Midland Company
NYSE:ADM
|
-0.014x |
Annual Cash Flow Conversion Efficiency for Alcon Inc. (2021–2025)
The table below shows the annual cash flow conversion efficiency of Alcon Inc. from 2021 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €0.00 | €2.27 Billion | x | -- |
| 2024-12-31 | €21.55 Billion | €2.08 Billion | 0.096x | +43.19% |
| 2023-12-31 | €20.62 Billion | €1.39 Billion | 0.067x | +8.81% |
| 2022-12-31 | €19.68 Billion | €1.22 Billion | 0.062x | -11.45% |
| 2021-12-31 | €19.26 Billion | €1.34 Billion | 0.070x | -- |